Showing results (11-20 of 85) with videos related to
Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
A phase II study of continuous infusion 5-fluorouracil (5-FU) with epirubicin and cisplatin in metastatic, hormone-resistant prostate cancer: an active new regimenD Chao, M von Schlippe, S J HarlandClinical Pharmacology and Therapeutics|September 1, 1980
Polymorphic acetylation of hydralazineJ A Timbrell, S J Harland, V FacchiniEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Carboplatin dose in combination chemotherapy for testicular cancerS J Harland, L A Gumbrell, A HorwichClinical Pharmacology and Therapeutics|March 1, 1981
Effect of dose on acetylator phenotype distribution of hydralazineJ A Timbrell, S J Harland, V FacchiniBritish Journal of Urology|September 1, 1996
The management of superficial bladder cancer: an interactive seminarJ P McFarlane, B W Ellis, S J HarlandBritish Journal of Cancer|September 24, 2004
Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancerA J Birtle, J C Newby, S J HarlandHuman Toxicology|May 1, 1985
A study of the effects of rifampicin on isoniazid metabolism in human volunteer subjectsJ A Timbrell, B K Park, S J HarlandBritish Journal of Cancer|September 15, 2001
Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosisM von Schlippe, C J Fowler, S J HarlandExperimental Pathology|January 1, 1990
Induction of fine structural alteration in cardiac Purkinje cells by ischaemic metabolites depends on oxygen tensionL C Armiger, S J Harland-Smith, R L EagarHistopathology|March 22, 2001
The role of the histopathologist in the management of testicular germ cell tumour in adultsM C Parkinson, S J Harland, P Harnden, et al.Pageof 9